A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer

A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer

Objective: Significant efforts are currently being made to identify novel biomarkers for the diagnosis and risk stratification of prostate cancer (PCa). Metabolomics can be a very useful approach in biomarker discovery because metabolites are an important read-out of the disease when characterized i...

Full description

Bibliographic Details
Main Authors:	Denise Drago, Annapaola Andolfo, Ettore Mosca, Alessandro Orro, Luigi Nocera, Vito Cucchiara, Matteo Bellone, Francesco Montorsi, Alberto Briganti
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2021-05-01
Series:	Cancer Biology & Medicine
Subjects:	prostate cancer eps-urine metabolomics prediction diagnosis
Online Access:	http://www.cancerbiomed.org/index.php/cocr/article/view/1861

Similar Items

A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer
by: Lizhu Chen, et al.
Published: (2022-02-01)

1H-NMR-based urine metabolomics of prostate cancer and benign prostatic hyperplasia
by: Mohammed Zniber, et al.
Published: (2024-04-01)

Urine Biomarkers for Prostate Cancer Diagnosis and Progression
by: Jeremy Clark, Rachel Hurst, Mark Simon Winterbone, Hardev Pandha, Antoinette Perry, Sophie McGrath, Richard Morgan, Adele E Connor, Asia C Jordan, Deirdre Winrow, Colin Cooper
Published: (2021-05-01)

Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics
by: Ana Rita Lima, et al.
Published: (2021-03-01)

Untargeted Metabolomics Study of Three Matrices: Seminal Fluid, Urine, and Serum to Search the Potential Indicators of Prostate Cancer
by: Magdalena Buszewska-Forajta, et al.
Published: (2022-03-01)

Molecular forms of human prostate-specific antigen in urine of subjects with benign prostatic hyperplasia
by: Kosanović Maja, et al.
Published: (2006-01-01)

EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients
by: Yang Liao, et al.
Published: (2022-04-01)

Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
by: Micael F. M. Gonçalves, et al.
Published: (2023-02-01)

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
by: Nagjie Alijaj, et al.
Published: (2022-02-01)

Direct N-Glycosylation Profiling of Urine and Prostatic Fluid Glycoproteins and Extracellular Vesicles
by: Calvin R. K. Blaschke, et al.
Published: (2021-09-01)

Volatile organic compounds for early detection of prostate cancer from urine
by: Qi Liu, et al.
Published: (2023-06-01)

Evaluation of the efficacy of post prostatic massage urine cytology in diagnosis of various prostatic lesions with cytohistological and clinical correlation
by: Monisha Choudhury, et al.
Published: (2017-01-01)

Novel Metabolic Signatures of Prostate Cancer Revealed by <sup>1</sup>H-NMR Metabolomics of Urine
by: Bo Yang, et al.
Published: (2021-01-01)

Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
by: Alina Cernasev, et al.
Published: (2021-06-01)

Co-EP-Ness and EP-Ness Involving the Inverse along an Element
by: Honglin Zou, et al.
Published: (2023-04-01)

Detection of miRNAs in urine of prostate cancer patients
by: Kristina Stuopelytė, et al.
Published: (2016-01-01)

Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy
by: Joakim Örtegren, et al.
Published: (2023-02-01)

Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer
by: Marcelino Yazbek Hanna, et al.
Published: (2023-01-01)

PrEP Familiarity, Interest, and Usage Among 364 Black and Hispanic Adults in Indiana
by: Jessica T. Campbell, et al.
Published: (2022-05-01)

Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men
by: Shuji Isotani, et al.
Published: (2023-09-01)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
by: Xin Jin, et al.
Published: (2022-06-01)

Relative Gene Expression Analysis from Urine Samples of Patients with Prostate Disease
by: Jasmin Ramić, et al.
Published: (2018-06-01)

Determination of the association of urine prostate specific antigen levels with anthropometric variables in children aged 5-14 years
by: Ioannis Efthimiou, et al.
Published: (2010-04-01)

Treatment of laundry wastewater using extracellular polymeric substances (EPS)
by: Sushil Kumar, et al.
Published: (2023-04-01)

“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
by: Elizabeth C. Pasipanodya, et al.
Published: (2021-05-01)

Do the values of prostate specific antigen obtained from fresh and dried urine reflect the serum measurements?
by: Hasan S Saglam, et al.
Published: (2013-01-01)

Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer Patients
by: Samanta Salvi, et al.
Published: (2021-03-01)

Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
by: Tânia Lima, et al.
Published: (2022-04-01)

Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression
by: Evgeniy A. Lekchnov, et al.
Published: (2018-12-01)

Comparative plasma and urine metabolomics analysis of juvenile and adult canines
by: Taibo Wu, et al.
Published: (2023-01-01)

Relationship between Urine Creatinine and Urine Osmolality in Spot Samples among Men and Women in the Danish Diet Cancer and Health Cohort
by: Selinay Ozdemir, et al.
Published: (2021-11-01)

Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients
by: Yoko Koh, et al.
Published: (2022-05-01)

Characterization of LC-MS based urine metabolomics in healthy children and adults
by: Xiaoyan Liu, et al.
Published: (2022-06-01)

ELISA‐based quantification of neurotrophic growth factors in urine from prostate cancer patients
by: Brayden March, et al.
Published: (2021-11-01)

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study
by: Anna K. Campos, et al.
Published: (2016-09-01)

Successful Integration of HIV PrEP in Primary Care and Women’s Health Clinical Practice: A Model for Implementation
by: Eunice Casey, et al.
Published: (2023-06-01)

In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice
by: Amalia Katafigioti, et al.
Published: (2016-10-01)

Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
by: Johanna Bödder, et al.
Published: (2023-01-01)

Urine Metabolome during Parturition
by: Federica Gevi, et al.
Published: (2020-07-01)

A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression
by: Yu Hu, et al.
Published: (2019-07-01)